About Admin

This author has not yet filled in any details.
So far Admin has created 97 blog entries.

Resilience Wins Three Department of Defense Awards Totaling More Than $16 Million

2021-03-30T15:18:34-04:00July 8th, 2020|

ALACHUA, Fla.--(BUSINESS WIRE)--Resilience Inc., a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has awarded the company with three biomanufacturing contracts with a combined value of more than $16 million.

Department of Defense Awards Resilience Contract to Advance Anti-Botulism Neurotoxin Monoclonal Antibodies

2021-03-30T15:18:55-04:00June 25th, 2020|

ALACHUA, Fla. – June 25, 2020 – Resilience Inc., a biologics contract development and manufacturing organization (CDMO), announced today it has been awarded a contract to advance development of a cocktail of anti-botulinum neurotoxin monoclonal antibodies (mAb) by the Department of Defense (DOD) through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). The contract ceiling value is $42.6 million.

Just – Evotec Biologics to Collaborate with Resilience on Antibodies Against Coronavirus

2020-04-30T13:52:05-04:00April 30th, 2020|

Ology and Just - Evotech Collaborate to Develop Antibodies Against Coronavirus Partnership is part of a contract awarded to Resilience by the Department of Defense to develop and manufacture monoclonal antibodies for treatment and prevention of infection with Sars-CoV-2 Just – Evotec Biologics to supply antibody screening and analytical characterization of anti-covid-19 antibodies

Go to Top